Cell-culture based influenza vaccine data

BCHXF announced results of a Phase I trial in 112 healthy adults. The vaccine is manufactured using a mammalian cell

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE